The constructed LyP1‐OMV@PD‐1 induced tumor cells to express PD‐1 through the release of PD‐1 plasmids, thereby achieving self‐blockade of the PD‐1/PD‐L1 pathway. Here, PTPN22 is linked to neoplasm.